These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6381231)

  • 21. The treatment of noninsulin-dependent diabetes mellitus (NIDDM, type II DM) becomes more and more complex.
    Meinders AE; Lemkes HH
    Neth J Med; 1990 Feb; 36(1-2):39-42. PubMed ID: 2179751
    [No Abstract]   [Full Text] [Related]  

  • 22. What nurses don't know about managing NIDDM.
    Wilson BA
    Medsurg Nurs; 1994 Apr; 3(2):152-4. PubMed ID: 8173627
    [No Abstract]   [Full Text] [Related]  

  • 23. Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients.
    Tseng CH; Huang TS
    Diabetes Res Clin Pract; 2005 Nov; 70(2):193-4. PubMed ID: 16188579
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
    Hausmann M; Dellweg S; Osborn C; Heinemann L; Buchwald A; Rosskamp R; Genova P; Heise T
    Diabetes Obes Metab; 2006 Sep; 8(5):574-80. PubMed ID: 16918593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral hypoglycemic agents as an alternative therapy for gestational diabetes.
    Hod M; Shafrir E
    Isr J Med Sci; 1995 Oct; 31(10):640-3. PubMed ID: 7591693
    [No Abstract]   [Full Text] [Related]  

  • 26. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
    Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
    Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral hypoglycaemic agents. When, how and why.
    Harris P; Colagiuri S
    Aust Fam Physician; 1997 Apr; 26(4):391-6. PubMed ID: 9115112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-monitoring of blood glucose: a test for patients or health-care professionals?
    Bhatnagar D
    Ann Clin Biochem; 2009 Jul; 46(Pt 4):271-2. PubMed ID: 19654101
    [No Abstract]   [Full Text] [Related]  

  • 29. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
    Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
    Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
    Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
    Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in diabetes care and management.
    Figge J; Figge HL
    Clin Orthop Relat Res; 1993 Nov; (296):31-6. PubMed ID: 8222444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tube feeding your diabetic patient safely.
    Bak LB; Heard KA; Kearney GP
    Am J Nurs; 1996 Dec; 96(12):47-9. PubMed ID: 8961863
    [No Abstract]   [Full Text] [Related]  

  • 33. [Testing insulin and sulfonylurea sensitivity in type II diabetes mellitus].
    Holländer E
    Orv Hetil; 1984 Dec; 125(51):3103-6. PubMed ID: 6392996
    [No Abstract]   [Full Text] [Related]  

  • 34. [Sulfonylureas].
    Sagreira L
    Acta Med Port; 1989 Sep; Suppl 1():9S-13S. PubMed ID: 2694782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin initiation in Type 2 diabetes.
    Page S
    Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
    [No Abstract]   [Full Text] [Related]  

  • 36. [A case from practice (158). Type I diabetes in remission. Type II diabetes].
    Skoda C; Spinas GA
    Schweiz Rundsch Med Prax; 1990 Jan; 79(1-2):25-6. PubMed ID: 2404332
    [No Abstract]   [Full Text] [Related]  

  • 37. Secondary failure to sulfonylureas in NIDDM. Are sulfonylureas still useful?
    Menon KN; Seshadri MS
    J Assoc Physicians India; 1990 Aug; 38(8):533-4. PubMed ID: 2123182
    [No Abstract]   [Full Text] [Related]  

  • 38. Insulin and oral sulfonylureas in the treatment of diabetes mellitus.
    White JR
    Am Pharm; 1992 Aug; NS32(8):39-43. PubMed ID: 1524021
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sulfonylurea compounds].
    Rosak G; Schöffling K
    Verh Dtsch Ges Inn Med; 1987; 93():180-6. PubMed ID: 3442100
    [No Abstract]   [Full Text] [Related]  

  • 40. [Peroral antidiabetics: sulfonylurea compounds].
    Kølendorf K
    Ugeskr Laeger; 1985 Jul; 147(30):2396-9. PubMed ID: 4060306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.